Page 729«..1020..728729730731..740750..»

VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th – GuruFocus.com

Posted: June 23, 2021 at 2:40 am

AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited ( AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on June 24th.

DATE: Thursday, June 24th TIME: 1:30 PM ETLINK: https://bit.ly/3c7Ertp

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at http://www.lifesciencesinvestorforum.com.

About VolitionRx Limited

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition's research and development activities are centered in Belgium, with a small laboratory in California and additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

For more information about Volition, visit Volition's website volition.com or connect with us via: Twitter: https://twitter.com/volitionrx LinkedIn: https://www.linkedin.com/company/volitionrx Facebook: https://www.facebook.com/VolitionRx/

The contents found at Volition's website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document. The addresses for Volition's website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

About Life Sciences Investor Forum

Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

See the article here:
VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th - GuruFocus.com

Posted in Epigenetics | Comments Off on VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th – GuruFocus.com

Integrative MedicineLeveraging Traditional Systems of Medicine – Sakshi English

Posted: June 23, 2021 at 2:38 am

By Dr. Krishna Reddy Nallamalla

One of the core purposes of medicine is to relieve suffering. Medicine has been evolving over millennia to serve this purpose across the world. Some of the oldest systems of medicine continue to thrive across the world. While traditional systems evolved through experiential wisdom, faith and belief, modern systems evolved through reason, analysis, and experimental evidence. Patient health seeking behavior is influenced by the prevailing culture, beliefs, prior experience, peer reference, ease of access, and the cost says Dr Krishna Reddy Nallamalla , President, InOrder & Country Director, ACCESS Health International.

Advances in modern medicine have significantly improved health status of populations. Despite these advances, people continue to suffer from unrelieved chronic pains, unexplained physical symptoms, and growing burden of life long non-communicable diseases and mental illnesses. Costs of modern healthcare have been growing faster than economic growth across the world accounting for impoverishment and inequity.

There is a growing emphasis on improving social determinants of health, healthy living, and prevention of illness. Similar shift is happening towards a holistic approach to health and disease. Traditional systems of medicine are being increasingly subjected to experimental evidence to understand their safety and effectiveness so as to integrate these systems with modern systems of medicine. This evolution underlies the concept of Integrative Medicine, wherein the best of both systems of medicine are used as per patients choice and response.

Every system of medicine, whether traditional or modern, has to be safe and effective in promoting health, preventing disease, treating an illness, and in providing relief from chronic incurable diseases. Both the systems should also demonstrate that they are cost-effective. Scientific analysis of traditional drugs, formulations, and methods may yield newer drugs and therapies. Lack of evidence in traditional therapies is not equivalent to lack of efficacy.

India is home to Ayurveda, one of the oldest systems of medicine. There are formal education systems for traditional systems and are grouped as AYUSH (Ayurveda, Unani, Siddha, and Homeopathy). A separate ministry oversees AYUSH systems of medicine. There are nearly 800,000 professionals qualified in AYUSH systems of medicine. While the majority practice their respective system of medicine, some of them choose to enter careers in public health, health management, and health informatics. Some even practice in allopathic settings as physician assistants. AYUSH professionals are also deployed as part of primary healthcare centers.

Increasingly AYUSH professionals are using the same diagnostic tools being used by allopathy professionals to diagnose underlying conditions and monitor the efficacy of their treatments. Conversely, allopathic professionals refer cases to AYUSH systems of medicine for some of the chronic ailments for which allopathic drugs are considered not effective or safe. Patients suffering from chronic pain, allergy, bowel disorders, mental disorders tend to seek alternate medicines. A sizeable number of patients with diabetes and high blood pressure prefer treatment from traditional systems.

Some of the leading medical institutes in the West are starting departments for Integrative Medicine with the adoption of some of the well-known traditional systems of medicine as part of providing holistic care to identified patients. Advanced research is being undertaken to validate the safety and efficacy of these practices and also to understand the possible mechanism behind their efficacy. Yoga and meditation are the most widely studied traditional systems of wellness.

Traditional systems of medicine are an integral part of Indias health system. They have evolved over millennia and survived to meet healthcare needs of people. They continue to be the only source of healthcare in some of the underserved areas. There is a growing acceptance of some parts of these systems globally with increasing scientific validation of their safety and efficacy. A well-designed research study comparing yoga-based cardiac rehabilitation was comparable to the modern cardiac rehabilitation methods. Unlike the modern system that requires elaborate infrastructure and manpower, yoga is simple to administer, amenable for home practice and is highly cost-effective.

More broad and rational integration of traditional systems of medicine into modern medical systems may aid in strengthening Indias health systems.

The author is President,InOrderCountry Director, ACCESS Health International.

Link:
Integrative MedicineLeveraging Traditional Systems of Medicine - Sakshi English

Posted in Integrative Medicine | Comments Off on Integrative MedicineLeveraging Traditional Systems of Medicine – Sakshi English

AIHM Fellowship in Integrative Health and Medicine Accepting Healthcare Practitioner Applicants and Awarding Scholarships for Oct 2021 Session – PR…

Posted: June 23, 2021 at 2:38 am

We encourage healthcare practitioners from a broad range of professions into our program as we know that we can improve healthcare through collaboration and sharing perspectives amongst all providers, said Mimi Guarneri, MD, FACC, ABOIM, Founding AIHM President.

SAN DIEGO (PRWEB) June 17, 2021

The Academy of Integrative Health and Medicine (AIHM) Interprofessional Fellowship in Integrative Health & Medicine, a 1000-hour hybrid program for clinicians who aim to become leaders in integrative health and medicine, has expanded its program and is accepting applications for October 2021. Rooted in evidence-based research, the Fellowship was launched in 2016 and blends online learning with clinical immersion experience. Scholarships are available on a limited first come first serve basis in these areas as well as others: licensed providers working with the underserved; allied healthcare professionals; and licensed providers from and/or working with BIPOC communities.

We encourage healthcare practitioners from a broad range of professions into our program as we know that we can improve healthcare through collaboration and sharing perspectives amongst all providers, said Mimi Guarneri, MD, FACC, ABOIM, Founding AIHM President.

We provide highly effective tools that can be integrated in their own practice to ultimately have a ripple effect of health and wellness through communities and cities, she added.

Fellows are licensed clinicians or licensed healthcare providers most of whom have their MD or DO or a masters degree. Participants typically become Fellows for continuing education and a meaningful connection to a deeper mission, often helping to address provider burnout and a desire to broaden their sense of purpose.

Nearly 200 graduates of the Fellowship apply their integrative approach to health and medicine in their work nationwide as doctors, nurses, acupuncturists, chiropractors and naturopaths among other professions. The online learning platform provides flexibility to take courses when convenient for the applicant, such as between seeing patients or in the evenings. Immersive experiences include virtual observation and interaction with leaders in Integrative Medicine practicing in a variety of clinical settings. This years online format allows for even more flexibility for working adult learners and a reduced environmental impact.

The curriculum includes a focus on integrative disease management, clinical immersion and self study, nutrition, botanicals and supplements, environmental and global health and more with courses building on the learning foundation in a progressive manner. Three retreats focus on the community and connection and reinforces the curriculum through experiential sessions in the beginning, middle and end of the program. One clinical immersion experience offers virtual input from expert faculty on actual patient case studies to help address patient needs.

More affordable than similar Fellowship programs in Integrative Health and Medicine, AIHMs Fellowship tuition is approximately $26,000. They offer equitable pricing through scholarships, institutional support, and match programs. Approximately fifty percent of Fellows are eligible for scholarships, with over $1 million awarded to date. Scholarships are based on financial need, work embedded within underserved communities, the cost of living in the state where the applicant lives as well as other factors.

The AIHM Fellowship in Integrative Health & Medicine was unanimously approved by the American Board of Integrative Medicine (ABOIM) committee in 2015. This means that MDs and DOs who successfully complete the Fellowship have satisfied ABOIM Eligibility Requirement 7(1) and are eligible to sit for the ABOIM exam. In March 2021, the AIHM Fellowship was also re-recognized by the Academic Consortium for Integrative Health & Medicine.

The Academy of Integrative Health and Medicine (AIHM) is a global interprofessional integrative health association working to transform health care - body, mind, spirit, community and planet. AIHM has been the leading professional organization for the holistic and integrative community since its formation in 1978. With the recent merger with the Academic Collaborative of Integrative Health (ACIH), the organization has combined forces with the most important pioneers of the integrative health movement for maximum impact. Together, they are creating health and wellness on a global scale through education, collaboration, and building a global movement.

Share article on social media or email:

See the original post:
AIHM Fellowship in Integrative Health and Medicine Accepting Healthcare Practitioner Applicants and Awarding Scholarships for Oct 2021 Session - PR...

Posted in Integrative Medicine | Comments Off on AIHM Fellowship in Integrative Health and Medicine Accepting Healthcare Practitioner Applicants and Awarding Scholarships for Oct 2021 Session – PR…

Enrich Your Massage Sessions with Sound Healing – Massage Magazine

Posted: June 23, 2021 at 2:38 am

Weve all experienced that moment when sound lifts us up; when that song you love comes on the radio just when you felt down and needed to hear it, or the sound of crashing ocean waves helps you fall asleep, or the Om you focus on during a meditation session brings you closer to a state of inner peace.

Music has been a medium of therapy for centuries, and there are numerous examples of the curative or healing powers of music in the historical records of different cultures, notes a 2010 article in the journal European Psychiatry.

Note that some people use the terms sound healing and music therapy interchangeably; they actually describe two different, but related disciplines. Both use instruments and the voice in order to produce a positive benefit, but sound healing is based on the frequency of sound, whereas music therapy relies on the structure and rhythm of music to bring about change. (Music therapy requires specific training and certification.)

For the purposes of this article, we will focus on the type of sound healing that can be done as part of a massage therapy session.

The human voice is often used in sound healing, as are several types of instruments: singing bowls, pan flutes, tuning forks, rattles, harps and drums. Practitioners believe that the sound and vibration each creates can resonate with specific parts of the body, dispelling negative energy and creating a positive effect.

The body of research in this area is relatively small, but anecdotal evidence is plentiful. One observational study, the results of which were published in 2016 in the Journal of Evidence-Based Complementary & Alternative Medicine, tested meditation with singing bowls.

Following the sound meditation participants reported significantly less tension, anger, fatigue, and depressed mood, the studys authors wrote.

Susan Cossette, a massage therapist and National Certification Board for Therapeutic Massage & Bodywork-approved education provider in Appleton, Wisconsin, built her knowledge of sound healing mainly via self-study.

One of the things that really touched my passion was reading Mitchell Gaynors Sound Of Healing book, because he had really studied how patients with cancer were incorporating crystal bowls into their recovery, she said. Gaynor, who died in 2015, was an oncologist and author who was a proponent of using complementary and alternative methods to supplement traditional medicine.

Based on her studies, Cossette created a workshop, Sounds of Healing, and says about 75% of her attendees are licensed massage therapists, nurses, chiropractors and others already in health care fields.

Tonia Lach, also an NCBTMB-approved education provider and massage therapist who practices in Sonoma, California, has studied acupressure and traditional Chinese medicine. She got into sound healing after receiving a crystal bowl as a gift, and experimenting with a chime on her own body. After seeking additional training, she developed a continuing education course in adding sound healing to massage sessions.

Like massage therapy sessions, sessions with sound therapy vary from therapist to therapist, and can be customized to each clients individual needs.

Cossettes sound healing sessions follow a progression. She usually begins with Tibetan tingshas, also called healing bells or cymbals; they produce low-frequency sounds that, like meditation, are intended to calm and focus the brain. She then will use other instruments, such as crystal bowls and tuning forks, to help the body release energy that is contributing to dis-ease or disharmony in the body.

As that energy is released, we dont want it lingering to settle back into the body, Cossette said. The tingshas bring it back to neutral so whatever theyve released doesnt settle back into their energy field and their physical body.

Cossette noted that there are many ways to incorporate sound into a massage session; she says she often plays a crystal bowl toward the end of a session, to clear the energy released during the session and send the client back out into the world with calm and positivity.

Lach has created her own signature offering called The Body Journey Massage Experience; it typically lasts 90 minutes to two hours, even to two and a half hours, giving her plenty of time to incorporate sound healing and hands-on bodywork.

Typically, I will begin the session with crystal bowls or rattles or chimes, Lach said. After the sound, then well work whatever modality is necessary physically, whether its deep tissue, acupressure, Swedish, lymphatic, reflexology, whichever is called for.

Lach described one session in which her client had just had eye surgery. After soothing her upper back, neck and shoulders with my chosen modalities, I decided to offer sound to the eye area to assist in releasing fear and promote healing, she said. With a light cover over her eyes, I got about three or four inches away and toned what sounded like a whispering bird tone over her eye for around three to four minutes.

After the session, she expressed how it felt like there was more space around her eyeball and that she felt more hopeful about the healing of her eye, Lach said.

The practitioner also benefits from sound healing; for one thing, its easier on the hands and body than providing massage therapy, and is not draining the way massage therapy can sometimes be for the therapist.

Also, When I tone in a session then I feel like it vibrates my body as well as the clients, so Im going to have sound healing as well just from the act of toning, Lach said.

Research on the subject of sound healing varies in quality and is relatively young, but studies do show that some sounds and frequencies seem to have a positive effect on the human body. The exact mechanism of action is still largely a mystery, but anecdotal evidence for the healing power of sound is plentiful.

In this article, well look at some recent research on sound as a healing modality, focusing on one major benefit it offers healthy adultsdrug-free relief from stress and anxiety. (Note: Sound healing, or sound therapy, is distinct from music therapy, which has to do with the structure and rhythm of music rather than sound frequencies, and requires its own training and certification. This article addresses the kind of sound healing that can be done in the massage session room, or practiced as self-care.)

At its most basic, sound is vibrationinvisible, physical waves that move through the air and are interpreted by the brain via the ear. The loudness of sound is measured in decibels (dB), while the frequency, or size of the waves, is measured in a unit called a hertz (Hz); the higher the number of hertzes, the higher-pitched the sound.

The human ear can detect a range of anywhere from 20 to 20,000 Hz, the average adult hearing range being about 2,000-5,000 Hz. Its finding the right frequencies, sound healing expert Jonathan Goldman told MASSAGE Magazine, that can have a positive effect on the human brain and body.

There are two basic ways that sound can affect us, said Goldman, the founder of the Sound Healers Association and co-author of The Humming Effect: Sound Healing for Health and Happiness (Healing Arts Press, 2017). Ones called psycho-acoustics, and thats where sound goes into our ears, into our brain and affects our nervous system, our heart rate, our respiration, our brainwaves, [our] blood pressure, he explained. The other is called vibro-acoustics, and that is where sound goes into the body, affecting you on a cellular level.

Sound healing, he noted, may work via the concept of entrainment, a physics term for the fact that two vibrating objects in proximity will come into resonance with one another, the lower frequency moving up to meet the higher frequency. If cells in the body are not vibrating at their natural, healthy frequency, sounds that match that frequency can help restore them to proper balance, he explained, thereby bringing about physiological change.

One of the most promising applications of sound healing, suggests recent research, is in the area of stress relief.

A 2019 study looked at the effects of a 30-minute sound meditation using the didgeridoo, an Australian wind instrument that produces a low, droning tone. The research, published in the journal Global Advances in Health and Medicine, divided 74 college undergraduate students into two groups, one of which experienced the didgeridoo meditation and one that underwent a 30-minute silent meditation.

After the intervention, while both groups reported increased relaxation and decreases in negative arousal, tiredness and acute stress, the didgeridoo group achieved significantly more relaxation and less stress.

Didgeridoo sound meditation is as effective as silent meditation for decreasing self-perceived negative arousal, tiredness, and energy and more effective than silent meditation for relaxation and acute stress reduction in undergraduate students, the studys authors concluded. Further investigation into didgeridoo sound meditation is warranted.

Another study, published in 2017 in The Journal of Evidence-Based Complementary & Alternative Medicine, studied the effects of Tibetan singing bowl sound meditation on mood, anxiety, pain and spiritual well-being in 62 men and women.

After the meditation session, participants reported significantly less tension, anger, fatigue, and depressed mood, as well as increased spiritual well-being, the studys authors wrote, concluding that Tibetan singing bowl meditation may be a feasible low-cost low technology intervention for reducing feelings of tension, anxiety, and depression, and increasing spiritual well-being.

More research into the area of sound and stress is neededand the studies mentioned here are just a few of the pieces of research that show its efficacybut existing results suggest sound healing may help reduce stress by reducing cortisol, the stress hormone, and increasing oxytocin, the bodys feel-good hormone. (Salivary cortisol and oxytocin levels were not measured as part of the above-mentioned sound healing research, but these levels have been formally studied and found to change positively in response to some music therapy interventions.)

A 2020 research review article published in the journal Integrative Medicine, concluded that sound healing, along with several other ancient healing modalities, presents considerable potential for stress reduction globally.

While much more research remains to be done to replicate and expand the results of current sound healing studies, the field is moving in a positive direction. Nasiri Suzan, managing director of the Sound Healers Association, told MASSAGE Magazine about the success she has had using tuning forks with hospital patients to help lower blood pressure and reduce swellingand musician and scientist Anthony Holland has even been studying certain frequencies ability to shatter cancer cells.

The National Institutes of Health has currently funded research into sound and music therapy, Goldman noted, so new developments may be on the horizonand in our increasingly fast-paced, living-with-COVID world, people are eager to learn about interventions for their stress and general health, especially those that are natural, inexpensive, drug-free and available outside a physicians office.

We all innately understand the power of sound; it is present from the very beginning of our lives, when in the womb we can hear the sound of our mothers voice and heartbeat. Sound has the ability to excite us, soothe us and evoke emotions and memories in usand many believe certain sound frequencies even have the capability to heal us.

Cossettes number-one piece of advice for massage therapists interested in adding sound healing to sessions is to choose their instruments carefully. She says that over the internet, its difficult to determine the quality of an instrument; she recommends buying them from an experienced practitioner so you can try them out first.

Its important, she added, to find instruments that personally resonate with you. Sometimes a bowl may sound beautiful if someone else is playing it, she said. Then you go to play it and go whoa, that doesnt resonate with me.

Lach agreed that trying instruments before you buy is critical. She suggested starting with a small chime with good resonance, and working your way into other instruments. She also recommended getting comfortable with using your voice during sound healing sessions.

The most powerful instrument that we have is our human voice.

Allison M. Payne is an independent writer, editor and proofreader based in central Florida. Her recent articles for MASSAGE Magazine include The Self-Employed MTs Guide to Getting Health Insurance (April) and Are You (and Your Data) at Risk? 10 Cybersecurity Steps You Need to Take Now.

Read the rest here:
Enrich Your Massage Sessions with Sound Healing - Massage Magazine

Posted in Integrative Medicine | Comments Off on Enrich Your Massage Sessions with Sound Healing – Massage Magazine

Undergraduate course on the COVID-19 pandemic – Study International News

Posted: June 23, 2021 at 2:38 am

When we decided last summer to create an undergraduate course about pandemics, we faced skepticism. Werent students and instructors tired of the COVID-19 pandemic? And would looking at pandemics from the perspective of numerous disciplines make it hard to address the topic with depth, or would we achieve a sense of cohesion?

As an anthropologist, a biologist and a historian, we know that infectious diseases are about a lot more than biology and medicine. Historically, epidemics and pandemics have shaped the world around us, frommask-wearing habits during plague timesto the impact ofpolio on the Toronto school system of the 1950s.

And, just like COVID-19 has affected people differently depending on where they live and work or what social supports they have, so have epidemics of the past. The tragedy of ourlong-term care system isnt newand understanding how infectious diseases mightemerge and spreadand therefore how to contain them is a complex matter involving everything from the science of contagion and human behaviour to social systems and the social determinants of health.

At the University of Guelph, we created Pandemics: Culture, Science and Society. This multidisciplinary course was offered in a virtual format and open to students as an elective in all programs and to alumni as a complete series of twelve weekly panels per semester.

We initially intended for this to be offered in fall 2020 only, but we quickly realised the value of our approach. We decided to run the course again in winter 2021, with a focus on COVID-19 research and creative projects that emerged at our university, from the sciences and the social sciences to business and the arts. Over two semesters, we engaged with 80 experts and researchers, as well as 600 undergraduates and 300 alumni.

Themes for weekly panels included knowledge and misinformation; pandemics in history and the arts; animals, environments and pandemics; and community, agency and resilience. Students and alumni learned about disease modelling, the impacts of COVID-19 on our food systems, pandemics in the ancient world and the biology of infectious diseases. Each week, panellists faculty, post-doctoral fellows and other experts gave short presentations, followed by a moderated discussion.

We convened expert panels from departments of population medicine, integrative biology, geography and computer science to economics, sociology and anthropology, fine arts and music, history and others, engaging multiple disciplines at a time.

Panellists helped students and alumni sift through and make sense of the COVID-19 infodemic. Public health and media experts, mathematicians, biologists, psychologists and philosophers were able to answer questions on the usefulness of masks, suggest ways for students to navigate stressful disagreements with roommates or relatives about COVID-19, and help the class understand how testing models and vaccines were developed. Every week added another layer to class discussions.

As course organisers, we were learners too. Through class discussions, we learned how COVID-19 was affecting all of us students, alumni and panellists as many shared some of their experiences. The course demonstrated the ways in which academic knowledge and personal experience can relate and interact with each other.

We know thatpeople experience and explain epidemicsand pandemics in ways that are shaped by existing economic, political, technological and social circumstances and tensions. As anthropologist Lisa J. Hardy explains, to understand social and political responses to the global pandemic, it is essentialthat we continue to investigate xenophobia, inequality and racism alongside the biological impact because the effects of pandemics are unequal and shaped by societal divisions. This became one of the main themes of the course.

The course allowed us to explore our shared and individual experiences in living through COVID-19. Participants heard how different the experience of the pandemic has been based on factors such as sex and gender, socio-economic status, race and ethnicity, geographic location (for instance, rural versus urban), political circumstance, mental and physical health status and many other factors.

We learned about the resilience of the Canadianfood systemfrom farm to plate, as well as the ongoing challenges such as the reliance on migrant workers and bottlenecks in distribution. We gained insights into the experiences ofgrocery store workers,persons with disabilities,pets and their peopleandmusicians.

We benefited from expert discussions about the emergence and evolution of viruses, vaccine development and deployment,wastewater testingand many other technical topics. And, we witnessed the incrediblecreativityon display during a global crisis from colleagues across campus.

We also saw the potential benefits of virtual classrooms. The course and its weekly panels in a virtual format offered a model for linking students, alumni from all over Canada and the world, and researchers in an intellectual and supportive community. We believe the meaningful connections that were created would have been harder to develop in a large auditorium.

Even as the pandemic kept us apart physically, the course created a deeply engaging virtual community; some students and alumni told us the panels became a weekly high point for them, and alumni attendance and participation made it clear how much alumni value opportunities for lifelong learning that emerge from ongoing university engagement.

If the course felt for some like a community, it was in part because we were engaged in understanding the multifaceted dimensions and impacts of phenomena we were living through in different ways. So while this pandemic will pass, this course serves as a model for addressing complex and urgent challenges such as climate change, social and racial injustice, and global food and economic security.

By Elizabeth Finnis, Associate Professor, Sociology and Anthropology, University of Guelph; Sofie Lachapelle, Professor, History, University of Guelph, and T. Ryan Gregory, Professor and Department Chair, Department of Integrative Biology, University of Guelph

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Visit link:
Undergraduate course on the COVID-19 pandemic - Study International News

Posted in Integrative Medicine | Comments Off on Undergraduate course on the COVID-19 pandemic – Study International News

Nanomedicine in Central Nervous System Injury and Repair Market Report- Trends Key Programs Analysis and Competitive Landscape Analysis The Manomet…

Posted: June 23, 2021 at 2:30 am

Global Nanomedicine in Central Nervous System Injury and Repair Market, By Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines), Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

The nanomedicine in central nervous system injury and repair market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 51,419.82 million by 2028 and grow at a CAGR of 9.91% in the above-mentioned forecast period. Increase in the prevalence of central nervous system diseases such as Parkinsons disease, senile dementia, Alzheimer disease, ocular diseases among others drives the nanomedicine in central nervous system injury and repair market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Major Players:-

The major players covered in the nanomedicine in central nervous system injury and repair market report are Abbott, Ablynx N.V, California Life Sciences Association, CELGENE CORPORATION, Teva Pharmaceutical Industries Limited, GENERAL ELECTRIC COMPANY, Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc), Pfizer Inc, Nanosphere Inc, Johnson & Johnson Private Limited and BD among other domestic and global players.

Competitive Landscape and Nanomedicine in Central Nervous System Injury and Repair Market Share Analysis

The nanomedicine in central nervous system injury and repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanomedicine in central nervous system injury and repair market.

Nanomedicine is defined as the nanotechnology which is used for treating, diagnosing, preventing diseases and traumatic injury, and to control of human biological systems using engineered nanodevices and nanostructures at the molecular level. Nanomedicine uses nano-tools that are 1000 times smaller than a cell for treatment of single cell and is also used in polymer therapeutics, regenerative medicine and targeted drug delivery.

Rise in the awareness related to nanomedicine applications is the vital factor escalating the market growth, also rise in thegovernmentfocus in terms of high funding for life science research and technological advancements in manufacturing process of nanomedicine, increase in the use of nanomedicine as probe or contrast agent in medical imaging techniques to extend the application of imaging and to improve the quality of images and rise in the healthcare expenditures are the major factors among others driving the nanomedicine in central nervous system injury and repair market. Moreover, rise in the technological advancements and modernization in the healthcare devices and rise in the risingresearch and developmentactivities in the healthcare sector will further create new opportunities for nanomedicine in central nervous system injury and repair market in the forecasted period of 2021-2028.

For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

However, high cost associated with nanomedicine based devices, rise in the stringent government regulations and increase in the risk of environment contamination due to release of toxic nanomaterials are the major factors among others which will obstruct the market growth, and will further challenge the growth of nanomedicine in central nervous system injury and repair market in the forecast period mentioned above.

This nanomedicine in central nervous system injury and repair market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine in central nervous system injury and repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Nanomedicine in Central Nervous System Injury and Repair Market Scope and Market Size

The nanomedicine in central nervous system injury and repair market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

The nanomedicine in central nervous system injury and repair market is also segmented on the basis ofapplicationinto clinical oncology, infectious diseases, clinical cardiology, orthopedics and others.

Nanomedicine in Central Nervous System Injury and Repair Market Country Level Analysis

The nanomedicine in central nervous system injury and repair market is analysed and market size insights and trends are provided by product and application as referenced above.

The countries covered in the nanomedicine in central nervous system injury and repair market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanomedicine in central nervous system injury and repair market due to rise in the presence of technologically advanced healthcare infrastructure in this region. Asia-Pacific is the expected region in terms of growth in nanomedicine in central nervous system injury and repair market due to rise in the awareness about nanomedicine and high prevalence of chronic diseases in countries in the region.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT GET FREE COVID-19 SAMPLE@ https://www.databridgemarketresearch.com/covid-19-impact/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

The country section of the nanomedicine in central nervous system injury and repair market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine in central nervous system injury and repair market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for nanomedicine in central nervous system injury and repair market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine in central nervous system injury and repair market. The data is available for historic period 2010 to 2019.

Read More @ https://www.databridgemarketresearch.com/reports/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Customization Available: Global Nanomedicine in Central Nervous System Injury and Repair Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @Corporatesales@databridgemarketresearch.com

Original post:
Nanomedicine in Central Nervous System Injury and Repair Market Report- Trends Key Programs Analysis and Competitive Landscape Analysis The Manomet...

Posted in Nano medicine | Comments Off on Nanomedicine in Central Nervous System Injury and Repair Market Report- Trends Key Programs Analysis and Competitive Landscape Analysis The Manomet…

Donate Blood Stem Cells or Marrow | Rhode Island Blood Center

Posted: June 23, 2021 at 2:26 am

Donate Blood Stem Cells or Marrow

I Was Saved

After years of cancer treatment, Wesley needed her perfect match to cure her. She found it in aperfect stranger she now considers her blood sister

I Gave

Michaela's spur-of-the-moment decision turned out to be Wesley's life-saving match -- herperfectone-in-a-million match.

Research shows that cells from younger donors provide the greatest chance for transplant success. In fact, doctors request donors in the 18 to 44 age group more than 90% of the time.

18 to 44

45 to 60

One patient. One donor. That is how life-saving blood stem cell and marrow transplant matchesare made. Every three minutes someone is diagnosed with a blood cancer like leukemia. Thecure isin the hands of ordinarypeople, and it could be you.Through the Rhode Island Blood Center's partnership withBe The Match, the National Marrow Donor Program, you may find you are theone and only match forsomeone who doesn't have one in their family. Make today the day you sign up to save someone's life.

Complete some health questions and forms right here online to sign up. We will send you a cheek swab kit to do the rest.

A simple cheek swab you can easily complete yourself is all it takes. Donors and patients are matched by their HLA (human leukocyte antigen) type, which is different from matching blood types, and the results of the cheek swab tell us your type. Return your swabs right away!

Once you are on the registry, doctors search for a close match for their patients. You may match someone who has been waiting for a transplant now, or end up being someone's match in the future.

Stem cells arecollected right at the Rhode Island Blood Center througha process that is similar to donating blood platelets or red cells. It's called a PeripheralBlood Stem Cell Donation.You would receive five daily shots inyour armto boost thenumber of stem cells in your blood stream. Then you make thedonation, which takes 4 - 6 hours. Donors can experience bone pain from the stem cell boost. Recovery is usually quick, however --just one ortwo days after the donation is made.

Marrow donations are made at a hospital under anesthesia soyou do not feel any pain. Doctors remove a small amountof marrowfrom your pelvicbone with a needle. Recoveryis usually quick, though some donors may have aches and pains for several days to a few weeks. Your marrow naturally replenishes itself in fourto sixweeks.

I understand that:

If I match a patient:

I promise to:

Some conditions that would prevent you from becoming adonor:

Read more:
Donate Blood Stem Cells or Marrow | Rhode Island Blood Center

Posted in Rhode Island Stem Cells | Comments Off on Donate Blood Stem Cells or Marrow | Rhode Island Blood Center

Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting – BioSpace

Posted: June 23, 2021 at 2:24 am

BOSTON, June 17, 2021 /PRNewswire/ -- Next week, June 21-26, stem cell biotechnology company Asymmetrex will participate as a presenter and an exhibitor in the 2021 Annual Meeting of the International Society for Stem Cell Research. In an invited poster presentation (#345) and a company exhibitor display, Asymmetrex will introduce the virtual gathering of international stem cell scientists, physicians, and biotechnologists to its new technology for evaluating the potency of therapeutic tissue stem cells.

Potency tests assure doctors that a medicine has good quality and will be effective for treatment. Although potency tests are common for drug medicines, developing them for stem cell treatments has been difficult. For stem cell treatments, no reliable potency tests have been available.

At the June 21-26, 2021 Annual Meeting of the International Society for Stem Cell Research, stem cell biotechnology company Asymmetrex will present data and examples for a new test for evaluation of the potency of tissue stem cell treatments. The technology, called kinetic stem cell (KSC) counting, can tell doctors the number of live tissue-renewing stem cells in a treatment sample.

The President & CEO of Asymmetrex, James L. Sherley, M.D., Ph.D., explains, "Stem cell medicine has needed a quality and effectiveness index like drug specific activity for pharmaceuticals. What could work better than knowing the number of live tissue stem cells that can restore other tissue cells? That's what our KSC counting TORTOISE TestTM platform can tell doctors: the number of live stem cells in a treatment that can renew an organ or tissue."

Asymmetrex is currently focused on conducting preclinical and clinical evaluations of how well its tissue stem cell-specific data indicate the effectiveness of stem cell treatments in different patients. In his company's presentations at ISSCR 2021, Sherley says that he will also introduce the immediate benefits of KSC counting to stem cell scientists for their tissue stem cell research. "It's a no brainer that now knowing how many tissue stem cells are in experiments will greatly improve stem cell researchand, as a consequence, stem cell medicine."

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA (ARMI) and the Massachusetts Biotechnology Council (MassBio).

Media Contact: James L Sherley, jsherley@asymmetrex.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/asymmetrex-will-present-a-new-test-for-therapeutic-stem-cell-potency-at-the-isscr-2021-annual-meeting-301311815.html

SOURCE Asymmetrex, LLC

See original here:
Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting - BioSpace

Posted in Stem Cell Research | Comments Off on Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting – BioSpace

Jasper Therapeutics and Aruvant Announce Research Collaboration to Study JSP191, an Antibody-Based Conditioning Agent, with ARU-1801, a Novel Gene…

Posted: June 23, 2021 at 2:24 am

REDWOOD CITY, Calif. and NEW YORK and BASEL, Switzerland, June 21, 2021 /PRNewswire/ --Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, andAruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced that they have entered a non-exclusive research collaboration to evaluate the use of JSP191, Jasper's anti-CD117 monoclonal antibody, as a targeted, non-toxic conditioning agent with ARU-1801, Aruvant's investigational lentiviral gene therapy for sickle cell disease (SCD). The objective of the collaboration is to evaluate the use of JSP191 as an effective and more tolerable conditioning agent that can expand the number of patients who can receive ARU-1801, a potentially curative treatment for SCD.

"This research collaboration with Aruvant is the first to use a clinical-stage antibody-based conditioning agent and a novel clinical-stage gene therapy, giving this combination a clear advantage by moving beyond the harsh conditioning agents currently used for gene therapy and establishing this next-generation potentially curative treatment as a leader in sickle cell disease," said Kevin N. Heller, M.D., executive vice president, research and development of Jasper. "Our goal is to establish JSP191 as a potential new standard of care conditioning agent, broadly in autologous gene therapy and allogeneic hematopoietic stem cell transplantation."

Gene therapies and gene editing technologies generally require that a patient's own hematopoietic stem cells first be depleted from the bone marrow to facilitate the engraftment of the new, gene-modified stem cells through a process called conditioning. Other investigational gene therapies and gene editing approaches in SCD use a high-dose chemotherapy such as busulfan for the conditioning regimen, which can place patients at prolonged risk for infection and bleeding, secondary malignancy and infertility. ARU-1801 is currently the only gene therapy that has demonstrated durable efficacy using both a lower dose of chemotherapy and a different agent than busulfan with a more limited side effect profile. The Aruvant-Jasper partnership is focused on evaluating the potential of using JSP191, a highly targeted anti-CD117 (stem cell factor receptor) monoclonal antibody agent, as the foundationof a novel conditioning regimen for use in combination with ARU-1801 to further reduce the negative side effects while maintaining efficacy.

"The unique attributes of ARU-1801 enable us to bring a potentially curative one-time therapy to individuals with sickle cell disease that can be delivered in the safest way possible," said Will Chou, M.D., Aruvant chief executive officer. "By partnering with Jasper to evaluate the use of JSP191 with ARU-1801, we are one step closer to developing a next-generation definitive therapy with an even more patient-friendly conditioning regimen. We believe that this combination may be able to further expand the number of patients who can benefit from ARU-1801 in the future, including potentially those with more moderate disease."

About JSP191JSP191 is a humanized monoclonal antibody in clinical development as a conditioning agent that blocks stem cell factor receptor signaling leading to clearance of hematopoietic stem cells from bone marrow, creating an empty space for donor or gene-corrected transplanted stem cells to engraft. While hematopoietic cell transplantation can be curative for patients, its use is limited because standard high dose myeloablative conditioning is associated with severe toxicities and standard low dose conditioning has limited efficacy. To date, JSP191 has been evaluated in more than 90 healthy volunteers and patients. It is currently enrolling in two clinical trials for myelodysplastic syndromes (MDS)/acute myeloid leukemia (AML) and severe combined immunodeficiency (SCID) and expects to begin enrollment in four additional studies in 2021 for severe autoimmune disease, sickle cell disease, chronic granulomatous disease and Fanconi anemia patients undergoing hematopoietic cell transplantation.

About ARU-1801ARU-1801 is designed to address the limitations of current curative treatment options, such as low donor availability and the risk of graft-versus-host disease (GvHD) seen with allogeneic stem cell transplants. Unlike investigational gene therapies and gene editing approaches which require fully myeloablative conditioning, the unique characteristics of ARU-1801 allow it to be given with reduced intensity conditioning ("RIC"). Compared to myeloablative approaches, the lower dose chemotherapy regimen underlying RIC has the potential to reduce not only hospital length of stay, but also the risk of short- and long-term adverse events such as infection and infertility. Preliminary clinical data from the MOMENTUMstudy, an ongoing Phase 1/2 trial of ARU-1801 in patients with severe sickle cell disease, demonstrate continuing durable reductions in disease burden.

The MOMENTUM StudyAruvant is conducting the MOMENTUM study, which is evaluating ARU-1801, a one-time potentially curative investigational gene therapy for patients with SCD. This Phase 1/2 study is currently enrolling participants, and information may be found at momentumtrials.comwhich includes a patient brochure, an eligibility questionnaireand information for healthcare providers.

About Jasper TherapeuticsJasper Therapeutics is a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell. The company is advancing two potentially groundbreaking programs. JSP191, a first-in-class anti-CD117 monoclonal antibody, is in clinical development as a conditioning agent that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It is designed to enable safer and more effective curative allogeneic and autologous hematopoietic cell transplants and gene therapies. In parallel, Jasper Therapeutics is advancing its preclinical engineered hematopoietic stem cell (eHSC) platform, which is designed to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Both innovative programs have the potential to transform the field and expand hematopoietic stem cell therapy cures to a greater number of patients with life-threatening cancers, genetic diseases and autoimmune diseases than is possible today. For more information, please visit us at jaspertherapeutics.com.

About Aruvant SciencesAruvant Sciences, part of the Roivant family of companies, is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies for the treatment of rare diseases. The company has a talented team with extensive experience in the development, manufacturing and commercialization of gene therapy products. Aruvant has an active research program with a lead product candidate, ARU-1801, in development for individuals suffering from sickle cell disease (SCD). ARU-1801, an investigational lentiviral gene therapy, is being studied in a Phase 1/2 clinical trial, the MOMENTUM study, as a one-time potentially curative treatment for SCD. Preliminary clinical data demonstrate engraftment of ARU-1801 and amelioration of SCD is possible with one dose of reduced intensity chemotherapy. The company's second product candidate, ARU-2801, is in development to cure hypophosphatasia, a devastating, ultra-orphan disorder that affects multiple organ systems and leads to high mortality when not treated. Data from pre-clinical studies with ARU-2801 shows durable improvement in disease biomarkers and increased survival. For more information on the ongoing ARU-1801 clinical study, please visit http://www.momentumtrials.comand for more on the company, please visit http://www.aruvant.com. Follow Aruvant on Facebook, Twitter @AruvantSciencesand on Instagram @Aruvant_Sciences.

About RoivantRoivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants nimble and focused biopharmaceutical and health technology companies. For more information, please visit http://www.roivant.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/jasper-therapeutics-and-aruvant-announce-research-collaboration-to-study-jsp191-an-antibody-based-conditioning-agent-with-aru-1801-a-novel-gene-therapy-for-the-treatment-of-sickle-cell-disease-301316032.html

SOURCE Aruvant Sciences

Originally posted here:
Jasper Therapeutics and Aruvant Announce Research Collaboration to Study JSP191, an Antibody-Based Conditioning Agent, with ARU-1801, a Novel Gene...

Posted in Stem Cell Research | Comments Off on Jasper Therapeutics and Aruvant Announce Research Collaboration to Study JSP191, an Antibody-Based Conditioning Agent, with ARU-1801, a Novel Gene…

Stem Cell manufacturing Market All-Inclusive Research Report (20212027) : Includes Impact of COVID-19 The Manomet Current – The Manomet Current

Posted: June 23, 2021 at 2:24 am

Data Bridge Market Research has recently added a concise research on theGlobal Stem Cell Manufacturing Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Industry competitive structure is elaborated. As per study key players of this market are Thermo Fisher Scientific. Merck Group, Becton, Dickinson and Company. Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis Inc and more.

The Global Stem Cell manufacturing Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 18.59 billion by 2027 growing at a CAGR of 6.42% in the above-mentioned forecast period. The growing awareness towards diseases like cancer, hematopoietic disorders and degenerative disorders is going to drive the growth of the stem cell manufacturing market.

Download FREE PDF sample copy of this research report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-market

Global Stem Cell Manufacturing Market, By Product (Stem Cell Line, Instruments, Culture Media, Consumables), Application (Research Applications, Clinical Applications, Cell and Tissue Banking), End Users (Hospitals and Surgical Centers, Pharmaceutical and Biotechnology Companies, Clinics, Community Healthcare, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Healthcare Infrastructure growth Installed base and New Technology Penetration

Stem cell manufacturing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell manufacturing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell manufacturing market. The data is available for historic period 2010 to 2018.

The Global Stem Cell Manufacturing Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of stem cell manufacturing market for global, Europe, North America, Asia Pacific and South America.

Global Stem Cell Manufacturing Market Scope and Market Size

Stem cell manufacturing market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Major Market competitors/players:Global Stem Cell manufacturing Market

Some of the major players operating in the stem cell manufacturing market are Thermo Fisher Scientific. Merck Group, Becton, Dickinson and Company. Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis Inc, Osiris Therapeutics, Osiris Therapeutics, Vericel Corporation, AbbVie, American CryoStem, AM-Pharma, Anterogen.Co.,Ltd, Astellas Pharma, Bristol-Myers Squibb, Apceth Biopharma, Cellular Dynamics International, Rheacell, Takeda Pharmaceutical, Teva Pharmaceutical Industries Ltd. ViaCyte, VistaGen Therapeutics Inc, Translational Biosciences, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, among others.

Market Definition:

This market report defines the market trends and forecast the upcoming opportunities and threats of the stem cell manufacturing market in the next 8 years. Stem cell manufacturing is a process of extracting the cells either from bone marrow or peripheral blood cells and culturing the cells in the culture dish containing nutrient media. Stem cells can be isolated from umbilical cord blood, placenta, amniotic sac, amniotic fluid, adipose tissue and menstrual blood. Stem cell manufacturing is used in the cell therapy as well as in gene therapy. Stem cell therapy is under research for many diseases like degenerative diseases and hematopoietic disorders like sickle cell anemia, storage disorders. Now stem cells are also used in making the cell and tissue bank. Some of the cell culture banks are National Institute of Biomedical Innovation, Health and Nutrition and World Federation for Culture Collections.

Key Insights in the report:

Inquire about this report from our experts @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-stem-cell-manufacturing-market

Opportunities in the market

Major Market Drivers:

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Read the rest here:
Stem Cell manufacturing Market All-Inclusive Research Report (20212027) : Includes Impact of COVID-19 The Manomet Current - The Manomet Current

Posted in Stem Cell Research | Comments Off on Stem Cell manufacturing Market All-Inclusive Research Report (20212027) : Includes Impact of COVID-19 The Manomet Current – The Manomet Current

Page 729«..1020..728729730731..740750..»